Principle of Assay
Human HGFA Inhibitor 2 ELISA Kit (A5865) employs the sandwich enzyme immunoassay technique for the quantitative measurement of human HGFA Inhibitor 2 in serum, plasma or other biological fluids. An antibody specific for HGFA Inhibitor 2 has been pre-coated onto a 96-well microtiter plate. The standards and test samples are added into the wells and the HGFA Inhibitor 2 present in each sample is bound to the wells by the immobilized antibody. Following incubation, the wells are washed and then incubated with Biotinylated Anti-HGFA Inhibitor 2 Antibody, which binds the captured HGFA Inhibitor 2 present in each well. Following incubation, unbound biotinylated detection antibody is removed by washing, and an HRP-Avidin conjugate is added to the wells and the microtiter plate is incubated. Following incubation and washing, TMB substrate solution is then used to visualize the HRP enzymatic reaction by catalysis to produce a blue-coloured product that changes to yellow after addition of acidic stop solution. The density of yellow is proportional to the amount of HGFA Inhibitor 2 captured in each well. The concentration of HGFA Inhibitor 2 can then be calculated by reading the O.D. absorbance at 450nm in a microplate reader and referring to the standard curve.